The phalangeal extensor tendon is surrounded and fixed by connective tissue showing differently extended expansions of its intercellular spaces. This connective tissue runs in horizontal lamellae and forms connective tissue spaces around the dorsal extensor apparatus. The clinical importance of the connective tissue spaces is in the formation of gliding spaces and the diffusion of phlegmonas or purulent infection processes. The morphological differentiation of the cellular and intercellular elements of the dorsal connective tissue lamellae shows that the peritendinous gliding spaces around the dorsal aponeurosis are bordered by synovia-like cellular and noncellular structures. Besides mast cells and histiocytes many cells are seen that show all signs of activated fibroblasts. They form small groups of cells. These cells produce a mucoid dense bordering lamella that is opposite to the collagenous fibers of the dorsal aponeurosis. The intercellular matrix has importance both in fixing and mobilizing the phalangeal extensor tendons in the sheathless parts of the phalangeal extensor tendon.

Keywords:
Finger, Dorsal aponeurosis, Synovial membrane, Inflammation, Histology
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.